Source: Annual Congress 2009 - Animal models of airways inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Hagner, H. Garn, H. Renz (Marburg, Germany). Adrenomedullin – a protective factor in asthma?. Eur Respir J 2009; 34: Suppl. 53, 2096

Member's Comments

No comment yet.

Related content which might interest you: Airway resistances: Raw, sRaw, sReff – Which is the best determinant of airway function? Source: Annual Congress 2010 - Lung function from infancy to adulthood Year: 2010 Asthma in elderly – What is the difference? Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care Year: 2012 Targeting the IL-1β – IL-17A inflammatory axis for the treatment of viral-induced exacerbations of COPD Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Tuberculosis – An important risk factor for lung cancer Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010 LATE-BREAKING ABSTRACT: Bullying in children with asthma – What factors are associated with increased risk? Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy Year: 2012 Differential involvement of IκB kinases α and β in asthma and COPD Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Treatment of sarcoidosis – pentoxifylline Source: Annual Congress 2009 - Pleural and parenchymal diseases Year: 2009 The in vitro biology of PF-00610355 – a novel β2 adrenoceptor agonist with a long duration of action Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 The in-vitro pharmacology of PF-3429281 – A novel inhaled dual antimuscarinic/β2 adrenoceptor agonist Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 EGFR – a useful biomarker? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 α-b crystallin – a marker for inflammation in COPD patients Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Asthma medication and antibiotics – Cause or effect? Source: Annual Congress 2010 - Paediatric respiratory epidemiology: early origins of childhood asthma Year: 2010 BAMBI – A TGF-β pseudoreceptor with possible functional involvement in COPD and NTHI infection Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011 Oral glucocorticoid treatment of severe asthma – Current practice in the US Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 LATE-BREAKING ABSTRACT: The role of prostacyclin in endothelial – eosinophil interaction Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 The in-vitro pharmacology of PF-4522971 – A novel inhaled Muscarinic M3 Antagonist Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 How should we investigate the child with difficult asthma – Is there any evidence? Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma Year: 2010 Evaluation of difficult asthma – a single centre experience Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Chronic non-asthmatic cough – Are we nearer to define the airway pathology? Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Eosinophil cationic protein in children with respiratory allergies – When is it useful? Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy Year: 2011